Home | Innovate Healthcare

In many cases, these additional findings prompt providers to adjust their surgical plans, new data suggest.

Read more about Pre-op MRI reveals additional malignant lesions in up to 25% of breast cancer patients under 40

It has been well established that chronic stress can affect an individual both physically and psychologically but measuring its impact objectively has remained a challenge.

Read more about AI helps experts 'see' stress on routine CT scans

Abbott’s FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system.

Abbott's FreeStyle Libre 3 Continuous Glucose Monitor

Approximately 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors need to be replaced due to a risk of incorrect glucose readings. Abbott has received reports of 736 severe adverse events and seven deaths that may be related to this issue.

Read more about Abbott shares safety concerns with millions of CGM sensors—7 deaths reported

Read more about Optimize Your CCTA + Heartflow Program for Reimbursement Success in 2026

Listen to this webinar to gain a clear understanding of the CMS 2026 Final Rule and what it means for your CCTA + Heartflow program. Our experts will walk through key updates, including the new Category I Code for AI-Enabled Coronary Plaque Analysis (AI-CPA), the commercial payer coverage landscape, and 2026 payment rates for CCTA, FFRCT, and AI-CPA. In addition, learn real-world best practices to successfully add Plaque Analysis to your service line. We’ll also share actionable strategies to position your program for reimbursement success and operational efficiency in the year ahead.

The timing of this new guidance from the Heart Rhythm Society and American College of Cardiology could not have been better—the document went live just as CMS finalized its decision to cover cardiac ablation procedures performed in ASCs.

Read more about Cardiology groups share new recommendations for performing safe, effective cardiac ablations in ASCs

Gregg W. Stone, MD, Director of Academic Affairs for the Mount Sinai Health System and Professor of Medicine (Cardiology) and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai, discusses the ATHENS-HF Trial, a first-in-man study of a chronically-adjustbable, bi-atrial pressure sensing inter-atrial shunt from Adona Medical.

Gregg Stone, MD, spoke to Cardiovascular Business about early data from the ATHENS-HF trial. Ten heart failure patients were treated with the adjustable device, and each implant was a success.

Read more about Adjustable interatrial shunt for heart failure shows promise in first-in-human trial

We’re moving, but we’re not going far.

Read more about Special note from the editor

Read more about Implementing the New Barostim Category I Codes: A Clinical and Billing Perspective

Listen in

Listen in to this webinar to gain a deeper understanding of updates to coding and billing for Barostim that are effective on January 1, 2026. We'll cover coding and billing specifics for hospitals, ambulatory surgery centers and physicians across all payer types. It is critical that your team is aware of all the coding updates for 2026.

The largest healthcare system in the Middle East is partnering with Nvidia to decode the human genome. If successful, the AI-heavy project will translate almost the entire language of heredity into actionable information.

Read more about Healthcare AI today: AI succeeds Hippocrates, Amazon looms large, 2026 predictions begin

Argon Medical Devices Option Elite IVC filter

Image courtesy of Argon Medical Devices.

Customers are urged to stop using these devices right away.

Read more about IVC filter recalled due to injury risk